Elafin, an Inhibitor of Elastase, Is a Prognostic Indicator in Breast Cancer

Breast Cancer Research - United Kingdom
doi 10.1186/bcr3374
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

E-Cadherin as a Prognostic Indicator in Primary Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
2001English

DHX32 Expression Is an Indicator of Poor Breast Cancer Prognosis

Oncology Letters
Cancer ResearchOncology
2016English

TLR5: A Prognostic and Monitoring Indicator for Triple-Negative Breast Cancer

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2019English

Serum CA125 Level Is a Good Prognostic Indicator in Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
1990English

Serum CA125 Level Is a Good Prognostic Indicator in Lung Cancer

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
1991English

Immunofluorometrically Determined P53 Accumulation as a Prognostic Indicator in Italian Breast Cancer Patients

International Journal of Cancer
Cancer ResearchOncology
1998English

Nottingham Prognostic Index Is an Applicable Prognostic Tool in Non-Metastatic Triple-Negative Breast Cancer

Asian Pacific Journal of Cancer Prevention
2019English

miR‑320a Is an Independent Prognostic Biomarker for Invasive Breast Cancer

Oncology Letters
Cancer ResearchOncology
2014English

Moesin Is an Independent Prognostic Marker for ER‑positive Breast Cancer

Oncology Letters
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy